Targeted Alpha Therapy: A Breakthrough Advancement in the Treatment of Refractory Skin Cancer
In a groundbreaking study, researchers from Japan, led by Assistant Professor Hiroyuki Suzuki at Chiba University, have introduced a novel targeted alpha therapy (TAT) approach...